1.Fire filiform needle for 21 cases of cold Bi syndrome (arthralgia due to cold).
Ji-Ping XING ; Xiu-Ping WU ; Xiao-Chun ZHAO
Chinese Acupuncture & Moxibustion 2012;32(12):1128-1128
Acupuncture Therapy
;
instrumentation
;
Adult
;
Aged
;
Arthralgia
;
therapy
;
Female
;
Humans
;
Male
;
Middle Aged
;
Needles
2.Analysis of apnea in 229 cases of very low birth weight infants.
Xiu-jing WU ; Ya-ping XU ; Li-ping SHI
Chinese Journal of Pediatrics 2003;41(8):622-623
Apnea
;
epidemiology
;
pathology
;
therapy
;
Birth Weight
;
China
;
epidemiology
;
Female
;
Gestational Age
;
Humans
;
Infant, Newborn
;
Infant, Very Low Birth Weight
;
Male
;
Risk Factors
;
Time Factors
3.Neonatal chondrodysplasia punctata in a case.
Xiu-jing WU ; Li-ping SHI ; Xiao-lu MA
Chinese Journal of Pediatrics 2009;47(3):229-230
5.Advance in studies on hepatoprotective effect of Salvia miltiorrhiza and its main components.
Yuan YUAN ; Qin WU ; Jing-shan SHI ; Xiu-ping CHEN
China Journal of Chinese Materia Medica 2015;40(4):588-593
Dried roots and rhizomes of Salvia miltiorrhiza (Danshen) are among the most commonly used traditional Chinese medicines in clinic. The material basis for its efficacy mainly includes hydrophobic tanshinones and hydrophilic salvianolic acids. The traditional effects of Danshen are "removing stasis and relieving pain, activating blood to promote menstruation, clearing heart fire and tranquilization". According to modern pharmacological studies, Danshen and its main components have cardiovascular and cerebrovascular protective effect. Recent studies showed that Danshen and its main components also demonstrated protective effects on liver injury models induced by carbon tetrachloride, D-galactosamine, acetaminophen and alcohol. In this paper, the hepatoprotective effect and mechanism of Danshen were summarized and studied.
Animals
;
Chromatography, High Pressure Liquid
;
Drugs, Chinese Herbal
;
chemistry
;
pharmacology
;
Humans
;
Liver
;
drug effects
;
Protective Agents
;
chemistry
;
pharmacology
;
Salvia miltiorrhiza
;
chemistry
6.A case of neonatal protein C deficiency.
Yu BAO ; Li-ping SHI ; Xiu-jing WU
Chinese Journal of Pediatrics 2011;49(5):390-391
7.Research on immune-modulation effects and its mechanisms of Guizhi Fuling capsule and its active ingredient combination.
Yi-ping JIANG ; Xiu WU ; Na LI ; Liang CAO ; Gang DING ; Zhen-zhong WANG ; Wei XIAO
China Journal of Chinese Materia Medica 2015;40(15):3068-3071
The effects of Guizhi Fuling capsule and its active ingredient combination within different concentration on SPL proliferate were observed by MTT method. The ratio of CD80/86, CD3CD25 and CD3CD69 was used to evaluate cell activation effects of Guizhi Fuling capsule and its active ingredient combination by FCM. Guizhi Fuling capsule with concentration of 400 mg · L(-1)can promote spleen lymphocyte proliferation, as well as the active ingredient combination, which showed the obvious dose-effect relationship. Compared with control group, the difference has statistical significance (P≤0.01). The result of FCM showed that Guizhi Fuling capsule and its active ingredient combination can promote CD80 and CD86 expression on spleen lymphocyte, and also can increase CD25 and CD69 ratio between spleen CD3+ cells. Compared with control group, the difference has statistical significance (P≤0.01). Thus, Guizhi Fuling capsule and its active ingredient combination may have immune-modulate effects, and the mechanism may have a close relationship with the lymphocyte activation.
Animals
;
Capsules
;
Drugs, Chinese Herbal
;
analysis
;
pharmacology
;
Immunologic Factors
;
pharmacology
;
Lymphocyte Activation
;
drug effects
;
Male
;
Mice
;
Mice, Inbred BALB C
;
T-Lymphocytes
;
drug effects
;
immunology
8.Isolation and Primary Identification of Endophytic Fungi from Cephalotaxus hainanensis L.
Ping CHEN ; Hao-Fu DAI ; Xiu-Chao XIE ; Jiao WU ; Wen-Bin LIAO ; Wen-Li MEI ;
Microbiology 2008;0(09):-
Seventy-two strains of endophytic fungi were isolated from the healthy bark, branches and leaves of Cephalotaxus hainanensis L.. Sixty-eight of them were morphologically classified into Fungi Imperfecti, thirty-three sporulated were identified to five genera. For those did not sporulate, one was identified to Rhizoctonia sp., the rest were tentatively classified into Mycelia Sterilia. Four were identified to Basidiomycetes. The result indicated the endophytic fungi of C. hainanensis show a degree of tissue specificity. There were significant differences about the quantity, genera and composition between the fungi isolated from bark and those from branches and leaves.
9.Effect of LEEP knife to treat cervical lesion and its nursing
Chinese Journal of Modern Nursing 2013;19(17):2029-2031
Objective To observe the effect of LEEP knife in the treatment of cervical lesions and investigate its nursing methods.Methods Totals of 270 patients with cervical lesions were treated with LEEP knife.Their operative time,blood loss,postoperative CCT abnormal number after 3 months,number of cervical stenosis and cervical repair time were observed and compared with those of 220 cases who used conventional electric knife for surgery during the same time.Results The operative time and blood loss were (6.3 ± 0.8) min and(3.2 ±0.5) ml in the LEEP knife group,less than (17.3 ± 2.1) min and (8.0 ± 1.0) ml in the conventional group,and the differences were statistically significant (t =79.311 5,69.003 9,respectively;P <0.05).The number of cervical stenosis and postoperative CCT abnormal number after 3 months were 6 and 22 in the LEEP knife group,less than 21 and 55 in the conventional group,and the differences were statistically significant (x2 =5.386 2,25.991 8,respectively;P < 0.05).The cervical repair time was (13 ± 1)d in the LEEP knife group,shorter than (22 ± 2) d in the conventional group,and the difference was statistically significant (t ==64.691 1,P <0.05).Conclusions LEEP knife is an effective way to treat cervical lesions,with effective interventions,which can reduce blood loss,shorten recovery time after cervix,and decrease the number of cervical stenosis as well as postoperative CCT abnormal number.
10.Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer.
Ping ZHANG ; Cong-Ying XIE ; Shi-Xiu WU
Chinese Journal of Oncology 2007;29(10):773-777
UNLABELLEDOBJECTIVE To assess the efficacy of concurrent chemoradiation with paclitaxel and platinum and external irradiation, and to compare the effect of extensive regional field irradiation with conventional local field irradiation for locally advanced esophageal cancer.
METHODSFrom Oct. 2000 to Jan. 2006, 89 patients with locally advanced esophageal cancer were registered in this study. All patients were inoperable or refused to undergo operation. Patients were divided into two groups: extensive regional field group (51 patients) and conventional field group (38 patients). Patients received radiotherapy at a total dose of 60 Gy in 30 fractions within 7 weeks,and concurrent paclitaxel 125 mg/m2 on D1, cisplatin 20 mg/m2 on D1-D3, or oxaliplatin 130 mg/m2 on D2 in the fist and fourth week of external radiation.
RESULTSOf these patients, 87.6% completed the treatment regimen with a response rate of 75.5% and 66.7% in the extensive regional field group and conventional field group, respectively. Grade 3 or severe toxicities of leucopenia (33.3% vs. 23.7%), thrombocytopenia (76.0% vs. 2.6%), and esophagitis (17.7% vs. 26.3%) were observed in extensive regional field group and conventional field group, respectively. Major late toxic effect was lung fibrosis. There were no statistically significant differences in the incidence of the toxicity profile between two groups. The overall 3-year survival rates was 32.8%, and the overall 3-year recurrence and metastasis-free survival rates was 34.5%. The overall 3-year locoregional control rate was 44.0%. No significant difference was found between two groups in the 3-year survival (38.2% % vs. 28.1%, P = 0.59). For the patients with stage II and stage III cancers who completed the planned treatment, large regional field radiotherapy significantly improved the 3-year survival (57.3% vs. 22.2% , P = 0.03) or 3-year recurrent and metastasis-free survival (55.5% vs. 23.0%, P = 0.03) or 3-year locoregional control (65.9% vs. 30.2%, P = 0.02) than conventional field radiotherapy.
CONCLUSIONhistorical results, the combination of paclitaxel/platinum and radiation in this study can improve the survival for locally advanced esophageal, and the side effect is well tolerated. Compared with the conventional field group, concurrent chemoradiotherapy with the large regional field can significantly improve 3-year survival and locoregional control for stage II or stage III esophageal cancer.
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols ; adverse effects ; therapeutic use ; Carcinoma, Squamous Cell ; drug therapy ; pathology ; radiotherapy ; Cisplatin ; administration & dosage ; Combined Modality Therapy ; Esophageal Neoplasms ; drug therapy ; pathology ; radiotherapy ; Esophagitis ; chemically induced ; etiology ; Female ; Follow-Up Studies ; Humans ; Leukopenia ; chemically induced ; etiology ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Organoplatinum Compounds ; administration & dosage ; Paclitaxel ; administration & dosage ; Particle Accelerators ; Radiotherapy Dosage ; Radiotherapy, High-Energy ; adverse effects ; methods ; Remission Induction ; Survival Rate ; Thrombocytopenia ; chemically induced ; etiology